PeptideDB

HBV-IN-13

CAS: 2724228-72-0 F: C22H25NO7 W: 415.44

HBV-IN-12 is a potent hepatitis B surface antigen (HBsAg) inhibitor. From patent WO2021204252A1, compound 1_B.
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity HBV-IN-12 is a potent hepatitis B surface antigen (HBsAg) inhibitor. From patent WO2021204252A1, compound 1_B[1].
Name HBV-IN-13
CAS 2724228-72-0
Formula C22H25NO7
Molar Mass 415.44
Transport Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Reference [1]. Tetracyclic compound as hepatitis b surface antigen inhibitor. WO2021204252A1.